Presurgical evaluation of the AKT inhibitor MK-2206 in patients with operable invasive breast cancer. Background: Valproic acid (VPA) is a histone deacetylase (HDAC) inhibitor that increases apoptosis ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results